CV Sciences, Inc. (CVSI)
OTC Markets
Key stats Fiscal year 2025
Income statement
- Revenue
- 13,789,000 -12.2%
- Net income
- -958,000
- Gross profit
- 6,752,000
- Operating income
- -470,000
- Earnings per share
- -0.01
- R&D expense
- 122,000
Growth and profitability
- Gross margin
- 48.97
- Operating margin
- -3.41
- Net margin
- -6.95
- Return on equity
- -65.26
- Return on assets
- -13.76
- Free cash flow margin
- -3.74
Balance sheet
- Total assets
- 6,962,000
- Total liabilities
- 5,494,000
- Shareholders' equity
- 1,468,000
- Cash and equivalents
- 278,000
- Debt
- 1,649,000
- Net debt
- 1,371,000
- Current ratio
- 1.03
- Debt to equity
- 1.12
Cash flow and ratios
- Operating cash flow
- -407,000
- Free cash flow
- -516,000
Shareholder returns
- Shares outstanding
- 242,184,128
- Book value per share
- 0.01
Company information
- Headquarters
- San Diego, CA
- Exchange
- OTC Markets
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
CV Sciences, Inc. trades on OTC Markets under the ticker symbol CVSI. This page brings together its price chart, company profile, key financial figures and technical indicators.